Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement | Haematologica
Frontiers | From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management - ScienceDirect
Systemic amyloidosis from A (AA) to T (ATTR): a review - Muchtar - 2021 - Journal of Internal Medicine - Wiley Online Library
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Light chain (AL) amyloidosis: update on diagnosis and management | Journal of Hematology & Oncology | Full Text
Diagnostics | Amyloidosis Center
Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis | JACC: Cardiovascular Imaging
Cureus | Slip-Ups in the Diagnosis of Cardiac Amyloidosis: A Case Fatality in Point | Article
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
JCDD | Free Full-Text | Invasive and Non-Invasive Diagnostic Pathways in the Diagnosis of Cardiac Amyloidosis
Diagnostics | Free Full-Text | Multimodal Imaging and Biomarkers in Cardiac Amyloidosis
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis | Haematologica
Frontiers | From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis
Laboratory Testing in AL Amyloidosis | Download Scientific Diagram
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases - Garcia‐Pavia - 2021 - European Journal of Heart Failure -
Serum and tissue light-chains as disease biomarkers and targets for treatment in AL amyloidosis
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association | Circulation
Cardiac amyloidosis: An underdiagnosed/underappreciated disease - ScienceDirect
Systemic amyloidosis - The Lancet
Manni Mohyuddin on Twitter: "There were some simplifications here in this thread, but will be helpful for fellows interpreting these values, and for non-hematologists who place these consults! Thanks for reading, and
Mass spectra and m/z values for FLC in patients with AL amyloidosis.... | Download Scientific Diagram
Polyclonal Localized Light Chain Amyloidosis-A Distinct Entity?
